Original
Niveles séricos de la adipomioquina irisina en pacientes con enfermedad renal crónica
Serum levels of the adipomyokine irisin in patients with chronic kidney disease
Ana Rodríguez-Carmonaa, Miguel Pérez Fontána,d,
, Susana Sangiao Alvarellosb, Teresa García Falcóna, María Lara Pena Bellob, Andrés López Muñiza, Fernando Cordidoc,d
Autor para correspondencia
a Servicio de Nefrología, Hospital Universitario de A Coruña, La Coruña, España
b Instituto de Investigación Biomédica (INIBIC), Universidad de A Coruña, La Coruña, España
c Servicio de Endocrinología, Hospital Universitario de A Coruña, La Coruña, España
d Departamento de Medicina, Facultad de Ciencias de la Salud, Universidad de A Coruña, La Coruña, España
Leído
13740
Vecesse ha leído el artículo
3310
Total PDF
10430
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 18 | 5 | 23 |
| 2025 5 | 132 | 48 | 180 |
| 2025 4 | 110 | 22 | 132 |
| 2025 3 | 134 | 58 | 192 |
| 2025 2 | 130 | 13 | 143 |
| 2025 1 | 99 | 78 | 177 |
| 2024 12 | 108 | 34 | 142 |
| 2024 11 | 74 | 52 | 126 |
| 2024 10 | 80 | 36 | 116 |
| 2024 9 | 57 | 32 | 89 |
| 2024 8 | 80 | 73 | 153 |
| 2024 7 | 68 | 27 | 95 |
| 2024 6 | 85 | 40 | 125 |
| 2024 5 | 83 | 42 | 125 |
| 2024 4 | 78 | 44 | 122 |
| 2024 3 | 51 | 30 | 81 |
| 2024 2 | 56 | 38 | 94 |
| 2024 1 | 52 | 28 | 80 |
| 2023 12 | 40 | 25 | 65 |
| 2023 11 | 55 | 34 | 89 |
| 2023 10 | 42 | 26 | 68 |
| 2023 9 | 32 | 26 | 58 |
| 2023 8 | 41 | 31 | 72 |
| 2023 7 | 33 | 23 | 56 |
| 2023 6 | 50 | 25 | 75 |
| 2023 5 | 35 | 41 | 76 |
| 2023 4 | 30 | 21 | 51 |
| 2023 3 | 45 | 32 | 77 |
| 2023 2 | 42 | 22 | 64 |
| 2022 1 | 48 | 36 | 84 |
| 2022 12 | 65 | 34 | 99 |
| 2022 11 | 69 | 38 | 107 |
| 2022 10 | 60 | 51 | 111 |
| 2022 9 | 58 | 31 | 89 |
| 2022 8 | 67 | 53 | 120 |
| 2022 7 | 68 | 44 | 112 |
| 2022 6 | 103 | 57 | 160 |
| 2022 5 | 101 | 41 | 142 |
| 2022 4 | 188 | 55 | 243 |
| 2022 3 | 93 | 48 | 141 |
| 2022 2 | 98 | 53 | 151 |
| 2021 1 | 84 | 35 | 119 |
| 2021 12 | 90 | 55 | 145 |
| 2021 11 | 141 | 43 | 184 |
| 2021 10 | 129 | 44 | 173 |
| 2021 9 | 155 | 44 | 199 |
| 2021 8 | 95 | 52 | 147 |
| 2021 7 | 102 | 38 | 140 |
| 2021 6 | 111 | 32 | 143 |
| 2021 5 | 101 | 50 | 151 |
| 2021 4 | 287 | 100 | 387 |
| 2021 3 | 130 | 33 | 163 |
| 2021 2 | 92 | 39 | 131 |
| 2020 1 | 82 | 31 | 113 |
| 2020 12 | 75 | 21 | 96 |
| 2020 11 | 78 | 36 | 114 |
| 2020 10 | 77 | 24 | 101 |
| 2020 9 | 81 | 30 | 111 |
| 2020 8 | 120 | 29 | 149 |
| 2020 7 | 116 | 19 | 135 |
| 2020 6 | 128 | 39 | 167 |
| 2020 5 | 137 | 35 | 172 |
| 2020 4 | 193 | 28 | 221 |
| 2020 3 | 129 | 26 | 155 |
| 2020 2 | 158 | 34 | 192 |
| 2020 1 | 115 | 44 | 159 |
| 2019 12 | 98 | 29 | 127 |
| 2019 11 | 112 | 35 | 147 |
| 2019 10 | 118 | 25 | 143 |
| 2019 9 | 114 | 18 | 132 |
| 2019 8 | 69 | 30 | 99 |
| 2019 7 | 68 | 30 | 98 |
| 2019 6 | 65 | 28 | 93 |
| 2019 5 | 85 | 33 | 118 |
| 2019 4 | 114 | 48 | 162 |
| 2019 3 | 74 | 42 | 116 |
| 2019 2 | 51 | 47 | 98 |
| 2019 1 | 54 | 30 | 84 |
| 2018 12 | 195 | 35 | 230 |
| 2018 11 | 360 | 17 | 377 |
| 2018 10 | 182 | 12 | 194 |
| 2018 9 | 65 | 18 | 83 |
| 2018 8 | 42 | 13 | 55 |
| 2018 7 | 38 | 15 | 53 |
| 2018 6 | 59 | 15 | 74 |
| 2018 5 | 66 | 17 | 83 |
| 2018 4 | 67 | 11 | 78 |
| 2018 3 | 52 | 14 | 66 |
| 2018 2 | 50 | 10 | 60 |
| 2018 1 | 68 | 10 | 78 |
| 2017 12 | 73 | 10 | 83 |
| 2017 11 | 70 | 12 | 82 |
| 2017 10 | 69 | 11 | 80 |
| 2017 9 | 77 | 13 | 90 |
| 2017 8 | 92 | 8 | 100 |
| 2017 7 | 72 | 14 | 86 |
| 2017 6 | 65 | 10 | 75 |
| 2017 5 | 77 | 17 | 94 |
| 2017 4 | 76 | 6 | 82 |
| 2017 3 | 72 | 6 | 78 |
| 2017 2 | 55 | 9 | 64 |
| 2016 1 | 66 | 8 | 74 |
| 2016 12 | 86 | 10 | 96 |
| 2016 11 | 474 | 24 | 498 |
| 2016 10 | 517 | 40 | 557 |
| 2016 9 | 248 | 22 | 270 |
| 2016 8 | 11 | 0 | 11 |
Mostrar todo
